System Formulary Update
Antimalarial Agents
Situation
The Antimalarial Agents class review and formulary standardization was approved at the March 2022 System Pharmacy and Therapeutics Committee meeting.
Background
The following medications were reviewed: artemether/lumefantrine, artesunate, atovaquone/proguanil, hydroxychloroquine, chloroquine, primaquine, mefloquine, pyrimethamine, tafenoquine, quinine.
Assessment/Recommendations
Changes Effective: JUNE 21st
System P&T voted to include the following products on the UNC Health System Drug Formulary:
As a result, the following products will be removed from the inpatient drug formulary: